Johanne Silvain, MD, PhD is currently an Interventional Cardiologist in the Institute of Cardiology, Pitié-Salpêtrière University Hospital, Paris, France directed by Professor Michel Komajda. He works as a Senior Physician in the Coronary Care Unit directed by Professor Gilles Montalescot and was promoted Associate Professor in 2012. He graduated from the Pierre et Marie Curie 6 University School of Medicine in Paris, France (Sorbonne University) and has been following medical study in France including an experience abroad at the Mount Sinaï Hospital, New York, U.S.A and a postdoctoral training on molecular basis and genetic of thrombosis at University of Pennsylvania School of Medicine (UPENN) in Philadelphia, U.S.A. He completed his PhD on translation studies focusing on Genetic, Molecular and Pharmacological Approach of Coronary Thrombosis. His research interests expand from mechanisms of thrombosis to treatment and prevention of acute kidney injury in cardiac patients, as well as advancing treatments for acute coronary syndromes and acute myocardial infarction. He has produced several publications including publication in the New England Journal of Medecine, Lancet, JAMA, BMJ, Circulation, JACC and European Heart Journal in his main research interest of acute coronary syndromes (ACS), interventional cardiology and antithrombotic drugs. Johanne Silvain is a senior researcher in the INSERM unit UMRS937 for research in translational medicine and is a member of the ACTION study group (Allies in Cardiovascular Trilas Initiatives and Organized Networks) an Academic Research Organization specialized in clinical trial. The latest publication of the ACTION group concerns the ARCTIC trial, the ABOARD trial, the ATOLL trial, the CLOVIS-2 trial and the ongoing project includes the ANTARCTIC trial and the ALBATROSS trial (www.action-coeur.org).
To be completed